Skip to main content

Reimbursement

26
Jun 2020

The reimbursement of COVID-19 PCR testing to be reduced in Germany

The reimbursement for PCR tests for the detection of SARS-CoV-2 will be reduced from €59.00 to €39.40 per test starting from July 1, 2020, and the billing of the examination will be limited to five times in the case of treatment. This decision was made by the extended evaluation committee on June 10, 2020.
17
Jun 2020

Change in the reimbursement of medical aids in Switzerland

On May 27, 2020, the Federal Council adopted the modification of the Insurance Law (KVG/LAMal) on the reimbursement of medical aids and equipment. In the future, health insurers will have to bear the costs of the medical material regardless of whether it is used directly by the insured person, by a non-professional person, or by the nursing staff.
15
Jun 2020

Decisions about add-on reimbursement for medical devices in France in May 2020

The French High Authority for Health (HAS) regularly publishes new decisions about add-on reimbursement for medical devices. The decisions made in May 2020 concern various types of devices, including cardiovascular devices (self-expanding intracranial stents, TAVI), CT navigation kit for CT-guided percutaneous interventions and medical aids. A total of 8 decisions were made.
02
Jun 2020

Reimbursement application portal for digital health apps is live in Germany

The application portal for inclusion in the directory of digital health apps (DiGA) at the Federal Office for Drugs and Medical Devices (BfArM) has been online since May 27, 2020. The application, which can be submitted only electronically, is the first step for the respective health app to be reimbursed in the future as part of regular care.